Characterization of two α-galactosidase mutants (Q279E and R301Q) found in an atypical variant of Fabry disease

This publication has 28 references indexed in Scilit:

• Only sphingolipid activator protein B (SAP‐B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal α‐galactosidase in a detergent‐free liposomal system
  FEBS Letters, 1996
• Aggregation of the Inactive Form of Human α-Galactosidase in the Endoplasmic Reticulum
  Biochemical and Biophysical Research Communications, 1996
• Identification of tyrosine 108 in coffee bean α-galactosidase as an essential residue for the enzyme activity
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1995
• Human α-galactosidase gene expression: significance of two peptide regions encoded by exons 1–2 and 6
  Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
• Characterization of a Mutant α-Galactosidase Gene Product for the Late-Onset Cardiac Form of Fabry Disease
  Biochemical and Biophysical Research Communications, 1993
• Activator proteins and topology of lysosomal sphingolipid catabolism
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Expression, glycosylation, and intracellular distribution of human β-galactosidase in recombinant baculovirus-infected cells
  Biochemical and Biophysical Research Communications, 1990
• Glycosylation and Processing of High Levels of Active Human Glucocerebrosidase in Invertebrate Cells Using a Baculovirus Expression Vector
  DNA, 1988
• Partial Enzyme Deficiencies: Residual Activities and the Development of Neurological Disorders
  Developmental Neuroscience, 1983
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
  Nature, 1970